Announcement:

The results of a recent collaboration between Sanofi, GSK, Lilly, Vesalius Therapeutics, Leiden University, Heidelberg University, ElmorePathology and Newcells aimed at enhancing safety assessments has just been published. Find out how rat kidney gene co-expression networks has enabled biomarker identification and human translation for renal safety assessments.

Find out more

Home › Resources › Videos and webinars › Creating a Powerful NAM Respiratory Toxicology Strategy for Clinical Predictivity and IND Success

Creating a Powerful NAM Respiratory Toxicology Strategy for Clinical Predictivity and IND Success

During this fireside chat session, you will hear our 2 guest speakers discuss how to best devise a NAM (new approach methodologies) strategy to progress your respiratory compound through the pipeline including standardisation, trends and innovations in respiratory in vitro models.

Date: Thursday 17th October 2024

Speakers:

Dr Clive Roper – Director – Roper Toxicology Consulting Limited
Dr Megan Webster – Former Head of Lung – Newcells Biotech

Published

October 17, 2024

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View Today

Please enter the required details to view the webinar. You are not automatically signing up for receiving marketing emails.

Book a Call